AngioDynamics Inc (ANGO)
5.785
-0.08
(-1.45%)
USD |
NASDAQ |
Apr 25, 16:00
5.785
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics SG&A Expense (Quarterly): 35.98M for Feb. 29, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 35.98M |
November 30, 2023 | 34.75M |
August 31, 2023 | 38.22M |
May 31, 2023 | 36.52M |
February 28, 2023 | 34.24M |
November 30, 2022 | 36.84M |
August 31, 2022 | 36.64M |
May 31, 2022 | 37.94M |
February 28, 2022 | 29.14M |
November 30, 2021 | 33.28M |
August 31, 2021 | 33.39M |
May 31, 2021 | 32.95M |
February 28, 2021 | 28.62M |
November 30, 2020 | 29.39M |
August 31, 2020 | 26.26M |
May 31, 2020 | 26.43M |
February 29, 2020 | 31.14M |
November 30, 2019 | 31.11M |
August 31, 2019 | 27.83M |
May 31, 2019 | 29.26M |
February 28, 2019 | 27.10M |
November 30, 2018 | 28.52M |
August 31, 2018 | 26.84M |
May 31, 2018 | 24.40M |
February 28, 2018 | 25.73M |
Date | Value |
---|---|
November 30, 2017 | 26.51M |
August 31, 2017 | 27.46M |
May 31, 2017 | 24.56M |
February 28, 2017 | 26.47M |
November 30, 2016 | 27.31M |
August 31, 2016 | 27.66M |
May 31, 2016 | 27.90M |
February 29, 2016 | 27.86M |
November 30, 2015 | 29.46M |
August 31, 2015 | 29.11M |
May 31, 2015 | 29.76M |
February 28, 2015 | 26.27M |
November 30, 2014 | 28.96M |
August 31, 2014 | 27.39M |
May 31, 2014 | 30.93M |
February 28, 2014 | 27.14M |
November 30, 2013 | 27.48M |
August 31, 2013 | 26.65M |
May 31, 2013 | 26.72M |
February 28, 2013 | 24.57M |
November 30, 2012 | 25.58M |
August 31, 2012 | 25.44M |
May 31, 2012 | 22.21M |
February 29, 2012 | 20.24M |
November 30, 2011 | 20.47M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
26.26M
Minimum
Aug 2020
38.22M
Maximum
Aug 2023
32.50M
Average
33.12M
Median
SG&A Expense (Quarterly) Benchmarks
Becton Dickinson & Co | 1.213B |
Integer Holdings Corp | 45.80M |
Outset Medical Inc | 32.53M |
Perspective Therapeutics Inc | 1.694M |
Xtant Medical Holdings Inc | 20.45M |